Three NEJM reports published June 18, 2026 evaluate whether giving whole blood before reaching the hospital improves outcomes for patients with traumatic hemorrhage. Two randomized trials examine prehospital whole-blood resuscitation strategies, including the use of type O whole blood administered in the prehospital setting. The studies assess clinical effectiveness and consistency of findings across trials, focusing on measures of survival and/or recovery-related endpoints reported within each trial design. Taken together, the articles describe evidence that prehospital whole blood is associated with beneficial or consistently favorable results compared with the control approaches used in the randomized studies.
One report presents results from a randomized controlled trial of prehospital whole blood, while another evaluates prehospital resuscitation using type O whole blood specifically in trauma and hemorrhage. A third NEJM piece synthesizes the overall evidence from the two randomized trials, highlighting that results align across studies rather than diverging.
Across the sources, the common theme is that early, prehospital transfusion of whole blood is tested under randomized conditions and shows consistent evidence regarding its impact on outcomes in traumatic hemorrhage.
